Cleared Traditional

K021887 - CANNABINOID ENZYME IMMUNOASSAY, CATALOG 0070, 0071 (FDA 510(k) Clearance)

Aug 2002
Decision
69d
Days
Class 2
Risk

K021887 is an FDA 510(k) clearance for the CANNABINOID ENZYME IMMUNOASSAY, CATALOG 0070, 0071. This device is classified as a Enzyme Immunoassay, Cannabinoids (Class II - Special Controls, product code LDJ).

Submitted by Lin-Zhi International, Inc. (San Jose, US). The FDA issued a Cleared decision on August 15, 2002, 69 days after receiving the submission on June 7, 2002.

This device falls under the Toxicology FDA review panel. Regulated under 21 CFR 862.3870.

Submission Details

510(k) Number K021887 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 07, 2002
Decision Date August 15, 2002
Days to Decision 69 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary Summary PDF

Device Classification

Product Code LDJ — Enzyme Immunoassay, Cannabinoids
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.3870

Similar Devices — LDJ Enzyme Immunoassay, Cannabinoids

Healgen® Accurate Oral Fluid Drug Test, Healgen® Accurate Oral Fluid Drug Test COT
K223162 · Healgen Scientific, LLC · Mar 2023
Immunalysis Cannabinoids Urine Enzyme Immunoassay, Immunalysis cTHC Urine Calibrators, Immunalysis cTHC Urine Control Set
K151203 · Immunalysis Corporation · Jun 2015
LZI Oral Fluid Cannabinoids Enzyme Immunoassay, LZI Oral Fluid Cannabinoids Calibrators and LZI Oral Fluid Cannabinoids Controls
K141320 · Lin-Zhi International, Inc. · May 2015